“In recognition of the importance of open access to the biomedical sciences, the European Medical Research Councils (EMRC) of the European Science Foundation (ESF), at the instigation of its Core Group member Professor Josef Syka of the Czech Science Foundation and the Academy of Sciences of the Czech Republic (GA?R and AV?R), launched an activity to investigate what, if any, steps EMRC could usefully take to improve the open access landscape in the biomedical field across Europe…. The many valuable inputs from participants made it clear that the current model for accessing biomedical research is far from ideal and that all research stakeholders (funding agencies, publishers, research performing institutions, research libraries and learned societies) need to work together to shift to an open access model in the field. However, a number of potential hurdles, discussed in this briefing, remain to be overcome…. [T]his briefing makes a number of recommendations: 1. There is a moral imperative for open access: research papers should be made freely available to all to read, use and re-use, with appropriate acknowledgement, in order to maximise the value of biomedical research, build on the body of knowledge, accelerate the process of discovery and improve human health. 2. Individual agencies must work together to raise awareness of the moral imperative for open access: agencies and organisations that fund and perform research, libraries, publishers and researchers must work in concert to raise awareness of the moral imperative for open access publishing. National, European and international partnerships are the basis for the successful achievement of open access to research outputs. Specific actions that different agencies need to undertake in order to move towards this goal are outlined in this briefing. 3. All research stakeholders should work together to support the extension of Europe PubMed Central into a Europe-wide PubMed Central: in order to facilitate discoveries and innovation in biomedical research, research stakeholders should collaborate to establish a Europe-wide repository in biomedicine as a partner site to the US equivalent PubMed Central. The recently rebranded Europe PubMed Central represents a valuable means to achieving this goal, provided that the diversity of European partner mandates and policies can be integrated….”
Abstract: Both the impact factor of the journal and immediate full-text availability in Pubmed Central (PMC) have featured in editorials before.1-3 In 2004, the editor of the Cardiovascular Journal of Africa (CVJA) lamented, like so many others, the injustice of not having an impact factor, its validity as a tool for measuring science output, and the negative effect of a low perceived impact in drawing attention from publications from developing countries.1,4
Since then, after a selection process, we have been indexed by the Web of Science® (WoS) and Thomson Reuters (Philadelphia, PA, USA), and have seen a growing impact factor. In the case of PMC, our acceptance to this database was announced in 2012,2 and now we are proud that it is active and full-text articles are available dating back to 2009. The journal opted for immediate full open access (OA), which means that full-text articles are available on publication date for anybody with access to the internet.
“To assist HRA [Health Research Alliance] member organizations wishing to adopt a public access policy, the HRA Public Access Task Group partnered with the National Library of Medicine (NLM) to enable HRA member-funded awardees/grantees* to deposit their publications into PubMed Central (PMC)….The following is a template developed by the HRA Public Access Task Group in conjunction with the Scholarly Publishing and Academic Resources Coalition (SPARC) that can be used by organizations seeking to implement public access policies as a condition of award funding. This template is based on the policy developed by HRA member organization, Autism Speaks. …”
“The Health Research Alliance, a collaborative member organization of nonprofit research funders, is committed to maximizing the impact of biomedical research to improve human health….The HRA partnered with the National Library of Medicine (NLM) to enable HRA member-funded awardees to deposit their publications into PubMed Central (PMC) with an embargo no longer than 12 months….”
“A recent tweet from @openscience…
…asked me to support my claim in a 2012 interview that “more than 40 percent of the visitors to PubMed Centralcome from non-.edu domains.”
I’m glad to. But the answer is too long for Twitter, or at least I’d like to say more about it than I can fit in a tweet. So I’m giving it here….”
“NO HARM TO PUBLISHERS IS EVIDENT: • Publishers retain up to a 12?month embargo on NIH?funded papers before they are made available to the public without charge under fair use principles. • The Public Access requirement took effect in 2008. While the U.S. economy has suffered a downturn during the time period 2007 to 2011, scientific publishing has grown: – The number of journals dedicated to publishing biological sciences/agriculture articles and medicine/health articles increased 15% and 19%, respectively.5 – The average subscription prices of biology journals and health sciences journals increased 26% and 23%, respectively.6 – Publishers forecast increases to the rate of growth of the medical journal market, from 4.5% in 2011 to 6.3% in 2014.7 …
KEY FACTS ABOUT PMC: • Over 2.4 million articles are now in PMC. In addition to the NIH?funded papers deposited into PMC, publishers voluntarily deposit more than 100,000 papers per year. • Every weekday, 700,000 users access the database, retrieving over 1.5 million articles. • Based on internet addresses, an estimated 25% of users are from universities, 17% are from companies, and 40% from the general public …”
“Our open access policy
As a CRUK-funded researcher, we:
Require electronic copies of any research papers that have been accepted for publication in a peer-reviewed journal, and which acknowledge CRUK funding, to be made available through Europe PubMed Central(link is external) (Europe PMC) as soon as possible and no later than 6 months after publication.
Encourage you to select publishing routes that ensure the work is available immediately on publication in its final published form, wherever such options exist for their journal of choice and are compliant with our policy*.
Encourage, and where an article processing charge is paid, require, you to license research papers using the Creative Commons Attribution licence (CC-BY)(link is external)**, so they may be freely copied and reused (for example, for text- and data-mining purposes), providing that the original authors are properly credited. …”
“The National Library of Medicine today announced the departure of David J. Lipman, MD, who has served as the Director of the National Center for Biotechnology Information (NCBI) since its creation almost 30 years ago….
NCBI creates and maintains a series of databases relevant to biotechnology and biomedicine, and is a world-renowned and trusted resource for bioinformatics tools and services. Major NCBI databases include GenBank for DNA sequences and PubMed, one of the most heavily used sites in the world for the search and retrieval of biomedical information.
“It’s hard to think of anyone at NIH who has had a greater impact on the way research is conducted around the world than David Lipman,” noted NLM Director Patricia Flatley Brennan, RN, PhD. “Under his visionary leadership, NCBI has greatly improved access to biomedical information and genomic data for scientists, health professionals, and the public worldwide—something we now practically take for granted.”…Dr. Lipman has been an advocate for promoting open access to the world’s biomedical literature and launched PubMed in 1997, followed by the full-text repository, PubMed Central (PMC), in 2000. He was instrumental in implementing the NIH Public Access Policy whereby NIH-funded papers are made publicly available in PMC….”
“We harvest content from across platforms like PubMed Central, arXiv, SciELO and bring it all together in one place
One of the main features of ScienceOpen is that we are a research aggregator. We don’t select what we index based on discipline, publisher, or geography, as that just creates another silo. Enough of those exist already. What we need, and what we do, is to bring together research articles from across publishers and other platforms and into one space, where it is all treated in exactly the same way….”
“I am a text mining specialist in the Literature Services team of EMBL-EBI. My team runs and maintains the Europe PMC database, an archive of life-science literature. Our job is to make it easy for researchers to find articles and information they need.
I contribute to the development of the text mining infrastructure of the database. My colleagues and I develop methods to annotate articles and design searches by indexing articles based on specific search fields. We are a service-oriented team and work closely with the users to make researchers’ lives easier….”